Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Accounts Payables (2016 - 2025)

Macrogenics (MGNX) has disclosed Accounts Payables for 14 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 4.51% to $4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 4.51% decrease, with the full-year FY2025 number at $4.8 million, down 4.51% from a year prior.
  • Accounts Payables was $4.8 million for Q4 2025 at Macrogenics, down from $5.9 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $15.5 million in Q4 2021 to a low of $2.6 million in Q2 2022.
  • A 5-year average of $6.2 million and a median of $5.1 million in 2024 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: skyrocketed 428.94% in 2021, then crashed 73.43% in 2022.
  • Macrogenics' Accounts Payables stood at $15.5 million in 2021, then plummeted by 68.39% to $4.9 million in 2022, then surged by 31.52% to $6.4 million in 2023, then decreased by 22.19% to $5.0 million in 2024, then dropped by 4.51% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Accounts Payables are $4.8 million (Q4 2025), $5.9 million (Q3 2025), and $4.7 million (Q2 2025).